According to recent reports focusing on gold NPs (GNPs), some authors have identified the thioredoxin reductase (TrxR) enzyme as a new potential biological target of metal-based NPs in both cancer [28,29,30] and healthy [45] cell lines. This evidence concerns the gene PRDX5 and cancer.